We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
16 hedge funds and large institutions have $671K invested in Decoy Therapeutics in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% less ownership
Funds ownership: 0% → 0% (-0%)
16% less funds holding
Funds holding: 19 → 16 (-3)
22% less capital invested
Capital invested by funds: $859K → $671K (-$188K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Holders
16
Holders Change
-3
Holders Change %
-15.79%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$22.7K |
| 2 |
HKAM
Horizon Kinetics Asset Management
New York
|
+$7.56K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$45.4K |
| 2 |
Millennium Management
New York
|
-$37.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$35K |
| 4 |
VF
Virtu Financial
New York
|
-$17K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.56K |
